NL-OMON42793尚未招募不适用
Detection of aberrant androgen receptor transcripts in circulating tumour cells as a predictor of resistance to AR- directed treatment in patients with castration-resistant prostate cancer. - Detection of AR splice variants in CTC of men with CRPC.
niversiteit Antwerpen0 个研究点目标入组 15 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Willing and able to provide written informed consent
- •2. Male and age >= 18 years
- •3. Histologically or cytologically confirmed adenocarcinoma of the prostate
- •4. Patients eligible to receive enzalutamide or abiraterone acetate as judged by the treating physician
- •5. Patients with or without prior chemotherapy regimens
排除标准
- •1. Serious or uncontrolled co-existent non-malignant disease, including active and uncontrolled infection.
- •2. Not willing to comply with the procedural requirements (extra blood draw) of this protocol.
- •3. Any criteria which renders patients ineligible for new AR-directed therapy (i.e. abiraterone acetate, enzalutamide).
研究者
相似试验
招募中
1 期
Based on Androgen Receptor Gene to Study the Mechanism of Spleen Deficiency Damp-Heat Syndrome Depression with Seborrheic AlopeciaDepressionITMCTR2100004444Tongde Hospital of Zhejiang Province
已完成
2 期
Androgen receptor and estrogen receptor imaging in metastatic breast cancer patients10006291breast cancerNL-OMON39731niversitair Medisch Centrum Groningen20
进行中（未招募）
1 期
Dynamics of Androgen Receptor.MedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036920Term: Prostate cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036911Term: Prostate cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036912Term: Prostate cancer stage 0System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036917Term: Prostate cancer stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036919Term: Prostate cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036918Term: Prostate cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate cancerEUCTR2014-000476-26-NLetherlands Cancer Institute50
尚未招募
2 期
Dynamics of Androgen Receptor genomics and transcriptomics after neoadjuvant androgen ablation (DARANA)prostate cancerprostate carcinoma10038597NL-OMON40287Antoni van Leeuwenhoek Ziekenhuis60
尚未招募
不适用
Detection of Indirect Androgen Doping with a GnRH Analog (Leuprolide)ACTRN12609000629235Sydney South West Area Health Authority (SSWAHS)16